I found an #ASH2024 Swift-inspired photo zone and tested it out with @megvoda.bsky.social
@shematologist.bsky.social I have bracelets for you!
@shematologist.bsky.social I have bracelets for you!
December 6, 2024 at 7:59 PM
I found an #ASH2024 Swift-inspired photo zone and tested it out with @megvoda.bsky.social
@shematologist.bsky.social I have bracelets for you!
@shematologist.bsky.social I have bracelets for you!
December 6, 2024 at 6:25 PM
Loved starting my #ASH2024 getting the audience of PD’s up out of seats! Presented on #MedEd Innovative Humanities Curricula in Hematology with Visual Thinking Strategies 🎨 and Medical Improv🎭. @ash-hematology.bsky.social
December 6, 2024 at 7:33 PM
Loved starting my #ASH2024 getting the audience of PD’s up out of seats! Presented on #MedEd Innovative Humanities Curricula in Hematology with Visual Thinking Strategies 🎨 and Medical Improv🎭. @ash-hematology.bsky.social
I joined here in anticipation of #ASH2024 and this talk on #SoMe by @shematologist.bsky.social teaching us all her wisdom!
December 6, 2024 at 7:29 PM
I joined here in anticipation of #ASH2024 and this talk on #SoMe by @shematologist.bsky.social teaching us all her wisdom!
#ASH2024 Reducing daunorubicin during induction therapy for standard-risk acute lymphoblastic #leukemia is safe and results in a 4-fold decrease in invasive fungal infections 👇👇👇
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
A Reduced Daunorubicin Dose during Induction Is Equally Effective As Standard Dose in Children with Acute Lymphoblastic Leukemia (ALL) and Favorable Prognostic Features: Long-Term Results of the Phase...
Disclosures. Schrappe:JazzPharma, Servier, Amgen: Honoraria, Research Funding, Speakers Bureau. Cario:Jazz Pharmaceuticals: Other: travel support. Dalla-Po
ashpublications.org
December 7, 2024 at 6:37 PM
#ASH2024 Reducing daunorubicin during induction therapy for standard-risk acute lymphoblastic #leukemia is safe and results in a 4-fold decrease in invasive fungal infections 👇👇👇
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
#ASH2024 This is a huge leap forward! 3-y disease-free survival (DFS) with blinatumomab was 97.5% vs. 90.2% without blina in SR-Average patients, and 94.1% vs. 84.8%, respectively, in SR-High patients. Obs! 10/19 relapses in the blina arm involved CNS 👇👇
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group S...
Disclosures. Rau:Abbvie: Other: spouse currently employed; Servier: Other: Advisory board participation; Jazz Pharmaceuticals: Consultancy, Honoraria, Othe
ashpublications.org
December 7, 2024 at 6:20 PM
#ASH2024 This is a huge leap forward! 3-y disease-free survival (DFS) with blinatumomab was 97.5% vs. 90.2% without blina in SR-Average patients, and 94.1% vs. 84.8%, respectively, in SR-High patients. Obs! 10/19 relapses in the blina arm involved CNS 👇👇
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
#ASH2024 In PIVOT trial, hydroxyurea treatment at 20 mg/kg/day was well-tolerated in both children and adults with HbSC, and was associated with significantly fewer painful vaso-occlusive events and fewer hospitalizations 👇👇👇
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
Double-Blind, Placebo-Controlled Randomized Controlled Trial of Hydroxyurea for HbSC: Results of the Prospective Identification of Variables As Outcomes for Treatment (PIVOT) Trial
Disclosures. Ware:Nova Laboratories: Other: Medical Advisory Board; Theravia: Other: Medical Advisory Board; Merck Pharmaceuticals: Other: Medical Advisory
ashpublications.org
December 7, 2024 at 6:15 PM
#ASH2024 In PIVOT trial, hydroxyurea treatment at 20 mg/kg/day was well-tolerated in both children and adults with HbSC, and was associated with significantly fewer painful vaso-occlusive events and fewer hospitalizations 👇👇👇
ashpublications.org/blood/articl...
ashpublications.org/blood/articl...
No-one does themes better than ASH!!
Can’t wait to bust out my lehenga for the 2024 ASH President’s Reception #Bollywood dance party!
@ash-hematology.bsky.social #ASH2024 #hemesky
Can’t wait to bust out my lehenga for the 2024 ASH President’s Reception #Bollywood dance party!
@ash-hematology.bsky.social #ASH2024 #hemesky
November 28, 2024 at 2:34 PM
No-one does themes better than ASH!!
Can’t wait to bust out my lehenga for the 2024 ASH President’s Reception #Bollywood dance party!
@ash-hematology.bsky.social #ASH2024 #hemesky
Can’t wait to bust out my lehenga for the 2024 ASH President’s Reception #Bollywood dance party!
@ash-hematology.bsky.social #ASH2024 #hemesky
Thank you for the shout-out, @mpaimd.bsky.social!!
Full list of #ASH2024 Education Program sessions here:
www.hematology.org/meetings/ann...
… And don’t miss the Spotlight Sessions too! 🩸⭐️🩸
#Hemesky #ClassicalHeme
Full list of #ASH2024 Education Program sessions here:
www.hematology.org/meetings/ann...
… And don’t miss the Spotlight Sessions too! 🩸⭐️🩸
#Hemesky #ClassicalHeme
November 22, 2024 at 3:01 AM
Thank you for the shout-out, @mpaimd.bsky.social!!
Full list of #ASH2024 Education Program sessions here:
www.hematology.org/meetings/ann...
… And don’t miss the Spotlight Sessions too! 🩸⭐️🩸
#Hemesky #ClassicalHeme
Full list of #ASH2024 Education Program sessions here:
www.hematology.org/meetings/ann...
… And don’t miss the Spotlight Sessions too! 🩸⭐️🩸
#Hemesky #ClassicalHeme
... And don't miss this HemeTalks Podcast where my Education Program Co-Chair Dr. John Koreth & I talk about our experience with developing the #ASH2024 Education Program this year! 🩸📖🩸
#HemeSky #MedSky
share.transistor.fm/s/57df4e94
#HemeSky #MedSky
share.transistor.fm/s/57df4e94
November 21, 2024 at 6:24 PM
... And don't miss this HemeTalks Podcast where my Education Program Co-Chair Dr. John Koreth & I talk about our experience with developing the #ASH2024 Education Program this year! 🩸📖🩸
#HemeSky #MedSky
share.transistor.fm/s/57df4e94
#HemeSky #MedSky
share.transistor.fm/s/57df4e94
Are you all ready for #ASH2024?! 'Cause I know I am!
Shameless plug: Don't miss the 2024 #ClassicalHeme 🩸Education Program Sessions! As the 2024 ASH Education Program Co-Chair, I know this year will be the best yet... if i do say so myself. 😉
Read more here: ashpublications.org/ashclinicaln...
Shameless plug: Don't miss the 2024 #ClassicalHeme 🩸Education Program Sessions! As the 2024 ASH Education Program Co-Chair, I know this year will be the best yet... if i do say so myself. 😉
Read more here: ashpublications.org/ashclinicaln...
Education Program Provides Framework for Thinking About Patient Care in a Rapidly Changing Field | ASH Clinical News | American Society of Hematology
ashpublications.org
November 21, 2024 at 6:20 PM
Are you all ready for #ASH2024?! 'Cause I know I am!
Shameless plug: Don't miss the 2024 #ClassicalHeme 🩸Education Program Sessions! As the 2024 ASH Education Program Co-Chair, I know this year will be the best yet... if i do say so myself. 😉
Read more here: ashpublications.org/ashclinicaln...
Shameless plug: Don't miss the 2024 #ClassicalHeme 🩸Education Program Sessions! As the 2024 ASH Education Program Co-Chair, I know this year will be the best yet... if i do say so myself. 😉
Read more here: ashpublications.org/ashclinicaln...
December 8, 2024 at 10:17 PM
I would LOVE to know if there is one single talk at the American Society of Hematology's annual massive conference on COVID. #ASH2024
December 9, 2024 at 7:30 AM
Lovely sunset in San Diego at #ASH2024.
A bit hazy, like my jet-lagged brain, but I'm sure tomorrow will be another beautiful day!
@ash-hematology.bsky.social
A bit hazy, like my jet-lagged brain, but I'm sure tomorrow will be another beautiful day!
@ash-hematology.bsky.social
December 7, 2024 at 6:00 AM
Lovely sunset in San Diego at #ASH2024.
A bit hazy, like my jet-lagged brain, but I'm sure tomorrow will be another beautiful day!
@ash-hematology.bsky.social
A bit hazy, like my jet-lagged brain, but I'm sure tomorrow will be another beautiful day!
@ash-hematology.bsky.social
Tomorrow at #ASH2024 we'll present the MRFF DIAAMOND trial results:
- Oral 303: Efficacy & safety of avatrombopag combined with immunosuppression in treatment-naïve severe AA. Clinical results: 4.30pm, room 11 SDCC.
- Poster 1318: cellular & cell-free genomic results.
@ash-hematology.bsky.social
- Oral 303: Efficacy & safety of avatrombopag combined with immunosuppression in treatment-naïve severe AA. Clinical results: 4.30pm, room 11 SDCC.
- Poster 1318: cellular & cell-free genomic results.
@ash-hematology.bsky.social
December 7, 2024 at 5:37 AM
Tomorrow at #ASH2024 we'll present the MRFF DIAAMOND trial results:
- Oral 303: Efficacy & safety of avatrombopag combined with immunosuppression in treatment-naïve severe AA. Clinical results: 4.30pm, room 11 SDCC.
- Poster 1318: cellular & cell-free genomic results.
@ash-hematology.bsky.social
- Oral 303: Efficacy & safety of avatrombopag combined with immunosuppression in treatment-naïve severe AA. Clinical results: 4.30pm, room 11 SDCC.
- Poster 1318: cellular & cell-free genomic results.
@ash-hematology.bsky.social
Excited to be here in San Diego at 66th American Society of Hematology meeting. #ASH2024 The Johnson & Johnson Innovative Medicine team is sharing 100+ presentations and our pursuit to #getinfrontofcancer.
#Johnson&Johnson
www.jnj.com/oncology/get...
Getting in front of cancer at the 66th American Society of Hematology (ASH) Annual Meeting
Andreas Gerber, Worldwide Vice President of Oncology, shares Johnson & Johnson’s bold ambition to get in front of cancer. Read about the company’s success in hematologic malignancies, new pivotal data...
www.jnj.com
December 8, 2024 at 2:24 PM
Excited to be here in San Diego at 66th American Society of Hematology meeting. #ASH2024 The Johnson & Johnson Innovative Medicine team is sharing 100+ presentations and our pursuit to #getinfrontofcancer.
#Johnson&Johnson
www.jnj.com/oncology/get...
So sad I am missing #ASH2024 But if you’re there early enough be sure to check out the wonderful @gritsmanlab.bsky.social present exciting updates from my work at the therapy resistance workshop on Friday! 2-5pm in SDCC room 33!
December 6, 2024 at 3:52 AM
So sad I am missing #ASH2024 But if you’re there early enough be sure to check out the wonderful @gritsmanlab.bsky.social present exciting updates from my work at the therapy resistance workshop on Friday! 2-5pm in SDCC room 33!
The #ASH2024 spotlight shone on MPNRF-funded research from the Royston Lab! @DJ_Royston
Using spatial transcriptomics & AI, they revealed how MPNs are associated with widespread disruptions in bone marrow cellular architecture.
#MPNResearch
Using spatial transcriptomics & AI, they revealed how MPNs are associated with widespread disruptions in bone marrow cellular architecture.
#MPNResearch
January 17, 2025 at 3:14 PM
The #ASH2024 spotlight shone on MPNRF-funded research from the Royston Lab! @DJ_Royston
Using spatial transcriptomics & AI, they revealed how MPNs are associated with widespread disruptions in bone marrow cellular architecture.
#MPNResearch
Using spatial transcriptomics & AI, they revealed how MPNs are associated with widespread disruptions in bone marrow cellular architecture.
#MPNResearch
Dr. @bkmarcellino 's presented the results of the 2020 MPN Progression Pilot grant exploring TP53 disruption at her #ASH2024 presentation, bridging early ideas with new therapeutic possibilities. PPM1D + HDM2 inhibitors are now in the spotlight. Proof that funding bright minds fuels progress.
January 16, 2025 at 3:26 PM
Dr. @bkmarcellino 's presented the results of the 2020 MPN Progression Pilot grant exploring TP53 disruption at her #ASH2024 presentation, bridging early ideas with new therapeutic possibilities. PPM1D + HDM2 inhibitors are now in the spotlight. Proof that funding bright minds fuels progress.
ASH2024: Berichte der Expertinnen & Experten aus dem Kompetenznetz Maligne Lymphome e.V. (KML) sind jetzt online!
Heute endete das 66. Meeting der American Society of Hematologie (ASH). Der weltweit wichtigste Kongress zu hämatologischen Erkran...
weiterlesen
Heute endete das 66. Meeting der American Society of Hematologie (ASH). Der weltweit wichtigste Kongress zu hämatologischen Erkran...
weiterlesen
December 10, 2024 at 5:09 PM
ASH2024: Berichte der Expertinnen & Experten aus dem Kompetenznetz Maligne Lymphome e.V. (KML) sind jetzt online!
Heute endete das 66. Meeting der American Society of Hematologie (ASH). Der weltweit wichtigste Kongress zu hämatologischen Erkran...
weiterlesen
Heute endete das 66. Meeting der American Society of Hematologie (ASH). Der weltweit wichtigste Kongress zu hämatologischen Erkran...
weiterlesen